MedPath

Validation of the ICH Score for the Prediction of 12-month Functional Outcome in Patients With Primary Intracerebral Hemorrhage

Completed
Conditions
Intra Cerebral Hemorrhage
Interventions
Other: Phone interview
Registration Number
NCT05808777
Lead Sponsor
National Taiwan University Hospital
Brief Summary

The goal of this observational study is to analyze the validity of the intracerebral hemorrhage (ICH) Score and a new modified ICH score for the prediction of 12-month functional outcome in patients with primary ICH.

Participants who were admitted to NTUH rehabilitation ward will be followed up to 12 months after the onset of ICH. The follow-up will be conducted by phone interviews.

Detailed Description

The ICH Score had been utilized to predict the 30-day mortality after acute intracerebral hemorrhage (ICH), but there's still no reliable tool in predicting the long-term functional outcome in ICH patients. Recently, there have been some studies that use ICH score to predict the prognosis of functional outcome in ICH patients. However, most studies included patients in western societies. Relevant studies in Taiwan were scarce. The present study will follow up the patients with ICH, who were admitted to NTUH rehabilitation ward, up to 12 months post stroke. The follow-up will be conducted by phone interviews at certain time after the onset of ICH. Investigators aim to analyze the validity of the ICH Score for the prediction of 12-month functional outcome in patients with primary ICH. Investigators will also add other variables to see if the revised score could better predict the prognosis among ICH patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Aged 20 years or older
  • Had been admitted to a neurology, neurosurgery, or rehabilitation ward with a diagnosis of primary intracerebral hemorrhage (ICH)
  • Had a diagnosis of ICH confirmed by a brain computed tomography (CT)
  • Have written informed consent given by themselves or by their legal representative
Exclusion Criteria
  • ICH related to aneurysm, arteriovenous malformation, or trauma
  • Died before discharge

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ICHPhone interviewPatients were eligible for inclusion if they 1. were aged 20 years or older 2. had been admitted to a neurology, neurosurgery, or rehabilitation ward with a diagnosis of primary ICH 3. had a diagnosis of ICH confirmed by a brain CT 4. have written informed consent given by themselves or by their legal representative
Primary Outcome Measures
NameTimeMethod
Barthel index12-month after ICH onset

Barthel index score, range: 0-100, higher scores mean a better outcome

Modified Rankin scale12-month after ICH onset

Modified Rankin scale, range: 0-6, higher scores mean a worse outcome

Secondary Outcome Measures
NameTimeMethod
Rehabilitation treatment course12-month after ICH onset

Including inpatient rehabilitation and outpatient rehabilitation

Tube retention rate12-month after ICH onset

Including Nasogastric (NG) tube, Foley catheter, tracheal tube

Trial Locations

Locations (1)

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath